Pediatric Eye Disease Investigator Group (PEDIG)

Protocol: IXT2 - A Randomized Clinical Trial of Observation versus Occlusion Therapy for Intermittent Exotropia
Status: Closed
Start Date: 01/13/2010
End Date: 09/30/2012
Clinical Trial ID: NCT01032330
Public Dataset:  


A Randomized Clinical Trial of Observation versus Occlusion Therapy for Intermittent Exotropia

Protocol

Objectives:

  • To determine the effectiveness of occlusion for the treatment of IXT among patients aged 3 to <11 years who have baseline near stereoacuity of 400 arcsec or better by Preschool Randot stereotest
  •  To determine the natural history of IXT among patients aged 3 to <11 years who have baseline near stereoacuity of 400 arcsec or better by Preschool Randot stereotest

 Publications:

  1. Pediatric Eye Disease Investigator Group. A randomized trial comparing part-time patching with observation for children 3-10 years old with intermittent exotropia. Ophthalmology. Dec 2014;121(12):2299-2310.
  2. Pediatric Eye Disease Investigator Group. A randomized trial comparing part-time patching with observation for intermittent exotropia in children 12 to 35 months of age. Ophthalmology. Aug 2015;122:1718-25.
  3. Leske DA, Holmes JM, Melia BM, on behalf of Pediatric Eye Disease Investigator Group. Evaluation of the Intermittent Exotropia Questionnaire using Rasch analysis. JAMA Ophthalmol. Apr 2015;133(4):461-5.

 



Back

© 2007 -2017 Jaeb Center for Health Research
All forms and reports on this site require Adobe Acrobat Reader. Click HERE to download a free copy of Adobe.
Although JCHR supports various web browsers, only Internet Explorer version 11 is fully tested and validated to function on this site.
This site utilizes popup windows.